Statin pretreatment is protective despite an association with greater coronary artery disease burden in patients presenting with a first st-elevation myocardial infarction

Preventive Cardiology

Volumn 11, Issue 1, 2008, Pages 21-25

  Moran, Lynn ^a   Fugate, Tyler ^a   Xiang, Yufei ^a   Cianci, Christopher ^a   Matsumura, Martin ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; TROPONIN I;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART PROTECTION; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; HOSPITALIZATION;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TROPONIN I;

EID: 41149152274     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2007.07320.x     Document Type: Article

References (13)

1. Downs JR, Clearfield M, Weis S, et al; for the ATRG. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. JAMA. 1998;279:1615-1622.
2. Cannon CP, Braunwald E, McCabe CH, et al; the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
3. Ishii H, Ichimiya S. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: A retrospective study in patients undergoing primary percutaneous coronary intervention. Clin Ther. 2006;28:1812-1819.
4. Mulukutla SR, Marroquin OC, Smith C, et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol. 2004;94:1363-1366.
5. Pasceri V, Patti G, Nusca A, et al; for ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results fFrom the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study. Circulation. 2004;110:674-678.
6. Santopinto J, Gurfinkel EP, Torres V, et al. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin. Am Heart J. 2001;141:566-572.
7. Spencer FA, Allegrone J, Goldberg RJ, et al; for the Grace Investigators. Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study. Ann Intern Med. 2004;140:857-866.
8. Go AS, Iribarren C, Chandra M, et al; for Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006;144:229-238.
9. Saab FA, Eagle KA, Kline Rogers E, et al. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times. Am J Cardiol. 2004;94:1166-1168.
10. Fonarow GC, Wright RS, Spencer FA, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96:611-616.
11. Robinson CR, Martin JL, Zhang L, et al. Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. Am J Cardiol. 2006;97:7-9.
12. Sorajja P, Tcheng J, Guagliumi G. Adverse impact of multi-vessel disease on ST-segment recovery and clinical outcome in patients undergoing primary PCI for acute myocardial infarction [Abstract]. Circulation. 2004;110(17 suppl):III-663.
13. Akosah KO, Schaper A, Cogbill C, et al. Preventing myocardial infarction in the young adult in the first place: How do the National Cholesterol Education Panel III Guidelines perform? J Am Coll Cardiol. 2003;41:1475-1479.